Local Recruitment of Autologous Stem Cells via a Targeting Microgel for Precise Cartilage Repair without Surgery
Advanced Materials · 2025
DOI: 10.1002/adma.202505544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Gengming Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Microgels, Cartilage, Articular, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: the Strategic Priority Research Program of the Chinese Academy of Sciences, Science and Technology Innovation Program of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The treatment of advanced osteoarthritis (OA) remains clinically intractable due to the inability to regenerate multifocal cartilage defects, stemming from poor targeted recruitment of bone marrow‐derived mesenchymal stem cells (BMSCs) and the absence of a sustained chondrogenic microenvironment at the injury sites. In this work, an antibody‐mediated gelatin methacrylate‐based hydrogel microsphere modified by TGFβ‐affinity peptides (TRG microsphere) is developed, to precisely target and repair scattered cartilage injuries by only intraarticular injection without any surgical assistance. By leveraging the specific expression of type I collagen in OA cartilage lesions, the type I collagen antibodies anchoring on TRG's surface enable the specific and accurate targeting of the multiple injury areas that need regeneration. In the meantime, the TGFβ‐affinity peptides incorporated in the TRG microsphere can capture the endogenous TGFβ, a growth factor that can recruit BMSCs and promote their differentiation, to precisely induce the hyaline‐like cartilage regeneration locally. In a rat model of advanced OA, a single intra‐articular injection of TRG microspheres can repair scattered cartilage defects, restore glycosaminoglycan deposition, and alleviate joint dysfunction. This study proposes an injection‐based strategy that enables continuous recruitment of endogenous BMSCs for precise cartilage regeneration, eliminating complex invasive procedures and patient discomfort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
- Green Chemical Engineering Technology Research Center, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, 201210, China.
- Department of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
ORCID-Profile: Hengyi Lu
Förderung
- the Strategic Priority Research Program of the Chinese Academy of Sciences
- Science and Technology Innovation Program of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, G., He, S., He, X., Gong, X., Yin, J., Li, J., Zhang, H., Lu, H., Wang, Y., & Wang, B. (2025). Local Recruitment of Autologous Stem Cells via a Targeting Microgel for Precise Cartilage Repair without Surgery. Advanced Materials. https://doi.org/10.1002/adma.202505544
Vancouver
Zhang G, He S, He X, Gong X, Yin J, Li J, et al. Local Recruitment of Autologous Stem Cells via a Targeting Microgel for Precise Cartilage Repair without Surgery. Advanced Materials. 2025. doi:10.1002/adma.202505544
BibTeX
@article{Zhang2025,
author = {Zhang, Gengming and He, Sihan and He, Xiangming and Gong, Xueyi and Yin, Jiazhen and Li, Jiusheng and Zhang, Hongqi and Lu, Hengyi and Wang, Yunjia and Wang, Bo},
title = {Local Recruitment of Autologous Stem Cells via a Targeting Microgel for Precise Cartilage Repair without Surgery},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202505544}
}
EUVIMED